Atlas Trials

Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial)

Clinical trial NCT03934931 · COMPLETED

Trial details

NCT number
NCT03934931
Sponsor
University of California, San Francisco
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
TuberculosisLatent TuberculosisHIV/AIDS
Start date
2020-07-13
Primary completion
2022-09-29
Enrollment
1656

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.